Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Shares Outstanding (Diluted Average) (2018 - 2020)

Avai Bio's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $26.3 million for Q4 2020.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 424.16% to $26.3 million in Q4 2020 year-over-year; TTM through Dec 2020 was $26.3 million, a 424.16% increase, with the full-year FY2020 number at $1.0 million, down 78.06% from a year prior.
  • Shares Outstanding (Diluted Average) hit $26.3 million in Q4 2020 for Avai Bio, roughly flat from $26.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for AVAI hit a ceiling of $26.3 million in Q2 2020 and a floor of $931507.0 in Q1 2018.
  • Historically, Shares Outstanding (Diluted Average) has averaged $9.2 million across 3 years, with a median of $5.0 million in 2018.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 424.16% in 2020, down 78.06% in 2020.
  • Tracing AVAI's Shares Outstanding (Diluted Average) over 3 years: stood at $5.0 million in 2018, then changed by 0.0% to $5.0 million in 2019, then soared by 424.16% to $26.3 million in 2020.
  • Business Quant data shows Shares Outstanding (Diluted Average) for AVAI at $26.3 million in Q4 2020, $26.3 million in Q3 2020, and $26.3 million in Q2 2020.